Welcome to Doping.nl, the Anti-Doping Knowledge Center.
This site has been established to host information about doping in the broadest sense of the word, and about doping prevention.

The Anti-Doping Authority Netherlands (the Dutch Doping Authority for short) established this site and maintains it. The Doping Authority was founded in 1989 and it is one of the oldest NADOs in the world. Doping.nl was developed with financial support from the Dutch Ministry for Health, Welfare and Sport.

This website  was established because of the importance that the Doping Authority and the Ministry attach to the dissemination of information relevant to doping prevention. Disclosing and supplying relevant information is one of the cornerstones in the fight against doping in sport. However, in practice, a significant amount of information is still not available, or only available to a limited group of users. We therefore decided to bring together all the relevant information in a single site: Doping.nl.

The Doping Authority aims to supply as much information through this website as possible on an ongoing basis. The information will be varied but will focus primarily on: WADA documents like the World Anti-Doping Code, the International Standards like the Prohibited List, Doping Regulations, scientific articles and abstracts, decisions by disciplinary bodies (mainly CAS decisions).As well as making documents available, the Doping Authority aims to supply searchable documents when possible, and to add relevant keywords to ensure easy access.
In the future, Doping.nl will also become a digital archive containing older information that is no longer available elsewhere.

Target readers
This site has been designed for use by anti-doping professionals such as National Anti-Doping Organisations and International Federations but also for students, journalists and other people interested in the subject.

To use the lightbox option, you need to register.

More information explaining how to use this website can be found under "help".

Recently added documents More »

ITF 2017 ITF vs Adrian Barbu

In October 2017 the International Tennis Federation (ITF) has reported an anti-doping rule violation against the Romanian tennis player Adrian Barbu after his sample tested positive for the prohibited substances Metenolone and Nandrolone. After notification the Athlete gave a prompt admission, accepted the test result and a provisional suspension. He indicated his wish to avoid a hearing and that there are grounds for a reduced sanction. The Athlete stated that in 2016 he was was not active as tennis player and that he had used Deca Durabolin (Nandrolone) and Primobolan (Metenolone) until December 2016 without intention to enhance his sport performance. He registered with the ITF in April 2017 en returned to competition in May 2017 and wasn’t aware that the prohibited substances he used in 2016 might still be in his system when he was tested in August 2017. The ITF argued that the Athlete is not entitled to any reduction of the period of ineligibility and that his conduct was clearly significant negligent. However the ITF accepted that it can not rule out the possibility that the Athlete tested positive as a result of his use of these substances until December 2016. After deliberations between the Parties a settlement was reached in which the ITF accepts that the Athlete gave a prompt admission for his use of the prohibited substances without intention to enhance his sport performances. The Athlete accepts a 2 year period of ineligibility with disqualification of his results. The Athlete's period of ineligibility starts backdated on the date of the sample collection, i.e. 16 August 2017. Therefore the ITF Independent Anti-Doping Tribunal decides on 9 February 2018 to terminate the proceedings against the Athlete on the basis as agreed between the parties.

show » details »

ITF 2017 ITF vs Zeynep Sönmez

In January 2018 the International Tennis Federation (ITF) has reported an anti-doping rule violation against the Turkish minor tennis player Zeynep Sönmez after her sample tested positive for the prohibited substance Modafinil. After notification the Athlete gave a prompt admission, accepted the test result and a provisional suspension and waived her right to be heard. The Athlete explained that the violation was not intentional and that she had used prescribed medication as treatment for her narcolepsy to help her with her study and she was not aware that it contained a prohibited substance. The ITF accepted the Athlete’s explanation and evidence and establish that the violation was not intentional. Further it considers the Athlete’s prompt admission and that she bears no significant fault or negligence. Therefore the ITF decides on 3 April 2018 to impose 12 month period of ineligibility on the Athlete starting on the date of the sample collection, i.e. on 24 October 2017.

show » details »

The proceedings of the 2017 Macolin Anti-Doping Summit

The proceedings of the 2017 Macolin Anti-Doping Summit : a fresh look at the science, legal and policy aspects of anti-Doping / Antonio Rigozzi, Emily Wisnosky, Brianna Quinn. - Bern. - Editions Weblaw, 2017. - ISBN 9783906836966 __________________________________________________ This book sets out the proceedings of the 2017 Macolin Anti-Doping Summit. The Summit brought together many of the most experienced and knowledgeable specialists from various disciplines, encouraging open and thought-provoking discussions on each of the major facets of anti-doping (the science aspect, the legal aspect and the policy aspect), viewed through the lens of the 2015 World Anti-Doping Code in practice. Speakers delved into issues as diverse as whether anti-doping science and regulation are keeping pace with doping, whether the law is jeopardising anti-doping efforts, the impact of the new emphasis on intelligence operations in anti-doping cases, what anti-doping can learn from the athlete?s perspective and the ethical challenges currently faced in anti-doping efforts. __________________________________________________ Contents: I. Introduction comments and acknowledgments II. The <science> aspect - 1. Session introduction: Professor Martial Saugy - 2. A scientist's perspective: Professor David Cowan - 3. A lawyer's perspective: Dr Marjolaine Viret - 4. Panel discussion - Are anti-doping science and regulation keeping pace with doping?: Baron Dr Michel D'Hooghe, Dr Matthias Kamber, Dr Francesco Botre and Dr Peter Van Eenoo III. The <legal> aspect - 1. Session introduction: Mr Michele Bernasconi - 2. Legal issues with minor athletes under the Code: Mr Herman Ram - 3. Does the 2015 World Anti-Doping Code punish the <real cheaters> more harshly?: Ms Emily Wisnosky - 4. Shifting the focus from testing to intelligence & investigations - Lessons learned: Mr Mathieu Holz - 5. Addressing systematic failures within an anti-doping regime designed for individuals: Professor Ulrich Haas - 6. Panel discussion - Is the law killing anti-doping efforts: Mr Michael Beloff QC, Mr Mike Morgan, Ms Brianna Quinn, Mr Jacques Radoux and Mr Mario Vigna IV. The <policy> aspect - 1. Session introduction: Professor Philippe Sands QC. - 2. Overview of a current ethical challenge in anti-doping: Professor Andy Miah - 3. Panel discussion - What can anti-doping learn from the athlete perspective?: Mr Obadele Thompson, Mr Johannes Eder and Mr Lucas Tramer - 4. Psychological aspects of anti-doping - The decision to dope and the impact of getting caught: Dr Mattia Piffaretti - 5. <Independence> of the anti-doping process - From the involvement of international federations to the role of CAS: Professor Antonio Rigozzi - 6. Panel discussion - Outlook for the future of anti-doping: Full speed ahead or back to square one?: Mr Benjamin Cohen, Dr Paul Dimeo, Dr Bengt Kayser, Professor Denis Oswald and Mr Jaimie Fuller V. Closing remarks

show » details »

NZRU 2017 DFSNZ vs Jacob Nield

In November 2015 the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) informed DFSNZ about the results of Medsafe’s investigation into an internet drug supplier NZ Clenbuterol and provided DFSNZ details about the internet purchases of prohibited substances made by the rugby player Jacob Nield. Hereafter in December 2017 Drug Free Sport New Zealand (DFSNZ) has reported two anti-doping rule violations against the Respondent Jacob Nield for the use, attempted use and possession of the prohibited substance clenbuterol. The Respondent gave a prompt admission for possession and use of clenbuterol in 2014 and 2015 and accepted the provisional suspension and the sanction proposed by DFSNZ. He didn’t file a statement in his defence nor did he attend the hearing of the New Zealand Rugby Union Judicial Committee. DFSNZ and The Committee establish that the Respondent gave a prompt admission and that there were substantial delays in the proceedings not attributed to the Respondent. Therefore the Judicial Committee decides in February 2018 to impose a 4 year period of ineligibility on the Respondent starting backdated on 5 February 2017.

show » details »
  • (Medical) Science
  • Doping classes
  • Education
  • History
  • Laboratories
  • Legal
  • Statistics
Publication period
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Document category
  • Document type
  • Health/Medical
  • IF'S
  • Laboratories/Analysis
  • Legal Terms
  • Organisations
  • Substances
  • Various
  • Version